KRAS and colorectal carcinoma: Our results contribute to a better understanding of the connection between KRAS and TP53. Knowledge of the pathways linking KRAS, TP53, and let-7a may provide greater insight into the mechanisms driving the poor phenotype observed in certain mutations in CRC.